These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 10786697)

  • 1. Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer.
    Inoue K; Slaton JW; Kim SJ; Perrotte P; Eve BY; Bar-Eli M; Radinsky R; Dinney CP
    Cancer Res; 2000 Apr; 60(8):2290-9. PubMed ID: 10786697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer.
    Inoue K; Slaton JW; Eve BY; Kim SJ; Perrotte P; Balbay MD; Yano S; Bar-Eli M; Radinsky R; Pettaway CA; Dinney CP
    Clin Cancer Res; 2000 May; 6(5):2104-19. PubMed ID: 10815938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
    Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of angiogenesis-related genes regulates different steps in the process of tumor growth and metastasis in human urothelial cell carcinoma of the urinary bladder.
    Chikazawa M; Inoue K; Fukata S; Karashima T; Shuin T
    Pathobiology; 2008; 75(6):335-45. PubMed ID: 19096229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
    Izawa JI; Sweeney P; Perrotte P; Kedar D; Dong Z; Slaton JW; Karashima T; Inoue K; Benedict WF; Dinney CP
    Clin Cancer Res; 2002 Apr; 8(4):1258-70. PubMed ID: 11948141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent administration of angiogenesis inhibitor TNP-470 (AGM-1470) at an optimal biological dose inhibits tumor growth and metastasis of metastatic human transitional cell carcinoma in the urinary bladder.
    Inoue K; Chikazawa M; Fukata S; Yoshikawa C; Shuin T
    Clin Cancer Res; 2002 Jul; 8(7):2389-98. PubMed ID: 12114444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of human metastatic transitional cell carcinoma of the bladder in a murine model with the anti-vascular endothelial growth factor receptor monoclonal antibody DC101 and paclitaxel.
    Inoue K; Slaton JW; Davis DW; Hicklin DJ; McConkey DJ; Karashima T; Radinsky R; Dinney CP
    Clin Cancer Res; 2000 Jul; 6(7):2635-43. PubMed ID: 10914704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice.
    Perrotte P; Matsumoto T; Inoue K; Kuniyasu H; Eve BY; Hicklin DJ; Radinsky R; Dinney CP
    Clin Cancer Res; 1999 Feb; 5(2):257-65. PubMed ID: 10037173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis.
    Huang S; Xie K; Bucana CD; Ullrich SE; Bar-Eli M
    Clin Cancer Res; 1996 Dec; 2(12):1969-79. PubMed ID: 9816156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of angiogenesis and metastasis-related genes for progression of transitional cell carcinoma of the renal pelvis and ureter.
    Inoue K; Kamada M; Slaton JW; Fukata S; Yoshikawa C; Tamboli P; Dinney CP; Shuin T
    Clin Cancer Res; 2002 Jun; 8(6):1863-70. PubMed ID: 12060629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fully human anti-interleukin 8 antibody inhibits tumor growth in orthotopic bladder cancer xenografts via down-regulation of matrix metalloproteases and nuclear factor-kappaB.
    Mian BM; Dinney CP; Bermejo CE; Sweeney P; Tellez C; Yang XD; Gudas JM; McConkey DJ; Bar-Eli M
    Clin Cancer Res; 2003 Aug; 9(8):3167-75. PubMed ID: 12912969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel enhances the effects of the anti-epidermal growth factor receptor monoclonal antibody ImClone C225 in mice with metastatic human bladder transitional cell carcinoma.
    Inoue K; Slaton JW; Perrotte P; Davis DW; Bruns CJ; Hicklin DJ; McConkey DJ; Sweeney P; Radinsky R; Dinney CP
    Clin Cancer Res; 2000 Dec; 6(12):4874-84. PubMed ID: 11156247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis.
    Deryugina EI; Soroceanu L; Strongin AY
    Cancer Res; 2002 Jan; 62(2):580-8. PubMed ID: 11809713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy of human bladder cancer with adenovirus-mediated antisense basic fibroblast growth factor.
    Inoue K; Perrotte P; Wood CG; Slaton JW; Sweeney P; Dinney CP
    Clin Cancer Res; 2000 Nov; 6(11):4422-31. PubMed ID: 11106263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenoviral-mediated gene therapy of human bladder cancer with antisense interleukin-8.
    Inoue K; Wood CG; Slaton JW; Karashima T; Sweeney P; Dinney CP
    Oncol Rep; 2001; 8(5):955-64. PubMed ID: 11496299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-alpha administration.
    Dinney CP; Bielenberg DR; Perrotte P; Reich R; Eve BY; Bucana CD; Fidler IJ
    Cancer Res; 1998 Feb; 58(4):808-14. PubMed ID: 9485039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis.
    Niu G; Wright KL; Huang M; Song L; Haura E; Turkson J; Zhang S; Wang T; Sinibaldi D; Coppola D; Heller R; Ellis LM; Karras J; Bromberg J; Pardoll D; Jove R; Yu H
    Oncogene; 2002 Mar; 21(13):2000-8. PubMed ID: 11960372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the VEGF, bFGF, aFGF and IL8 angiogenic activity in urinary bladder carcinoma, using the mice cutaneous angiogenesis test.
    Rogala E; Skopińska-Rózewska E; Sommer E; Pastewka K; Chorostowska-Wynimko J; Sokolnicka I; Kazoń M
    Anticancer Res; 2001; 21(6B):4259-63. PubMed ID: 11908679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo.
    Gershenwald JE; Sumner W; Calderone T; Wang Z; Huang S; Bar-Eli M
    Oncogene; 2001 Jun; 20(26):3363-75. PubMed ID: 11423987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of angiogenesis, tumor growth, and metastasis by transfection of vascular endothelial growth factor into LoVo human colon cancer cell line.
    Kondo Y; Arii S; Mori A; Furutani M; Chiba T; Imamura M
    Clin Cancer Res; 2000 Feb; 6(2):622-30. PubMed ID: 10690548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.